Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis

By sjmartinez • July 3, 2025

Budoff MJ, de Oliveira Otto MC, Li XS, Lee Y, Wang M, Lai HTM, Lemaitre RN, Pratt A, Tang WHW, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D. Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis. Sci Rep. 2025 Jul 2;15(1):23362. doi: 10.1038/s41598-025-05903-3. PMID: 40603925.

Tags: Cardiology/Epi, cardiovascular disease, CVD, Harbor UCLA, MACE, major adverse cardiac events, myocardial infarction, Nutrition, Publications, TMAO, Trimethylamine N-oxide

Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning

Dirakvand G, Pervin S, Villa B, Le C, Yohanna K, Grijalva V, Chattopadhyay A, Sinha SK, Reddy ST, Singh R. Follistatin Mitigates Atherosclerosis Through Activation[...]

Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke

Warach SJ, Weber JM, Alhanti B, Messé SR, Schwamm LH, Fonarow GC, Sheth KN, Smith EE, Mullen MT, Silva GS, Mac Grory B, Xian Y,[...]

Outcomes of Early Sodium-Glucose Cotransporter Two Inhibitor Use in Takotsubo Syndrome: Insights From a Multicenter Real-World Cohort Study

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]